DSM Inks $2.6B Spinoff Deal With JLL Partners
Royal DSM will create a new pharmaceutical company by spinning off its DSM Pharmaceutical Products business and combining it with a pharmaceutical manufacturer owned by private equity shop JLL Partners in...To view the full article, register now.
Already a subscriber? Click here to view full article